Thiomers: Promising platform for macromolecular drug delivery

Future Medicinal Chemistry

Volumn 4, Issue 17, 2012, Pages 2205-2216

  Laffleur, Flavia ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANION; CATION; DISULFIDE; EXCIPIENT; POLYMER; THIOL DERIVATIVE; THIOMER; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; ENZYME INHIBITION; MACROMOLECULE; MEMBRANE TRANSPORT; MUCOADHESION; OXIDATION; PH; PRIORITY JOURNAL; REVIEW; SYNTHESIS;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; MACROMOLECULAR SUBSTANCES; PHARMACEUTICAL PREPARATIONS; POLYMERS; SULFHYDRYL COMPOUNDS;

EID: 84870444656     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.165     Document Type: Review

References (75)

1. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56(11), 1649-1659 (2004).
2. Balenga NA, Zahedifard F, Weiss R, Sarbolouki MN, Thalhamer J, Rafati S. Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy. J. Biotechnol. 124(3), 602-614 (2006).
3. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107(3), 459-466 (2006).
4. Langguth P, Hanafy A, Frenzel D et al. Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound. Drug Dev. Ind. Pharm. 31(3), 319-329 (2005).
5. Wong HL, Rauth AM, Bendayan R et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 23(7), 1574-1585 (2006).
6. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 50(1), 161-177 (2000).
7. Bernkop-Schnürch A, Walker G. Multifunctional matrices for oral peptide delivery. Crit. Rev. Ther. Drug Carrier Syst. 18(5), 459-501 (2001).
8. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 12(1), 10-20 (2011).
9. Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur. J. Pharm. Sci. 42(5), 445-451 (2011).
10. Sakloetsakun D, Hombach JM, Bernkop-Schnürch A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials 30(31), 6151-6157 (2009).
11. Kast CE, Bernkop-Schnürch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22(17), 2345-2352 (2001).
12. Iqbal J, Shahnaz G, Dunnhaupt S, Muller C, Hintzen F, Bernkop-Schnürch A. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials 33(5), 1528-1535 (2012).
13. Bernkop-Schnürch A, Krauland AH, Leitner VM, Palmberger T. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur. J. Pharm. Biopharm. 58(2), 253-263 (2004).
14. Dunnhaupt S, Barthelmes J, Rahmat D et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol. Pharm. 9(5), 1331-1341 (2012).
15. Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm. Res. 20(6), 931-936 (2003).
16. Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnürch A. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J. Biomed. Mat. Res. Part A, 82(1), 1-9 (2007).
17. Salamat-Miller N, Johnston TP. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int. J. Pharm. 294(1-2), 201-216 (2005).
18. Gradauer K, Vonach C, Leitinger G et al. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Int. J. Nanomed. 7, 2523-2534 (2012).
19. Fu YM, Du LN, Wang Q et al. In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels. Pharmazie 67(4), 299-303 (2012).
20. Baloglu E, Ay Senyigit Z, Karavana SY et al. In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations. Chem. Pharm. Bull. (Tokyo) 59(8), 952-958 (2011).
21. Shahnaz G, Vetter A, Barthelmes J et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int. J. Pharm. 428(1-2), 164-170 (2012).
22. Hornof MD, Kast CE, Bernkop-Schnürch A. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur. J. Pharm. Biopharm. 55(2), 185-190 (2003).
23. Roldo M, Hornof M, Caliceti P, Bernkop-Schnürch A. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm. 57(1), 115-121 (2004).
24. Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res. 16(6), 876-881 (1999).
25. Habeeb AF. A sensitive method for localization of disulfide containing peptides in column effluents. Anal. Biochem. 56(1), 60-65 (1973).
26. Jindal AB, Wasnik MN, Nair HA. Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties. Indian J. Pharm. Sci. 72(6), 766-774 (2010).
27. Sharma R, Ahuja M. Thiolated pectin: synthesis, characterization and evaluation as a mucoadhesive polymer. Carbohyd. Polym. 85(3), 658-663 (2011).
28. Krauland AH, Bernkop-Schnürch A. Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Eur. J. Pharm. Biopharm. 57(2), 181-187 (2004).
29. Bernkop-Schnürch A, Clausen AE, Hnatyszyn M. Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int. J. Pharm. 226(1-2), 185-194 (2001).
30. Bernkop-Schnürch A, Leitner V, Moser V. Synthesis and in vitro characterization of a poly(acrylic acid)-homocysteine conjugate. Drug. Dev. Ind. Pharm. 30(1), 1-8 (2004).
31. Bilicic MB, Filipovic-Grcic J, Martinac A et al. Synthesis and characterization of thiomers of polyaspartamide type. Int. J. Pharm. 291(1-2), 211-219 (2005).
32. Kurimoto A, Tanabe T, Tachibana A, Yamauchi K. Thiolated dermal bovine collagen as a novel support for bioactive substances-conjugation with lysozyme. J. Biotechnol. 86(1), 1-8 (2001).
33. Weber C, Reiss S, Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int. J. Pharm. 211(1-2), 67-78 (2000).
34. Langoth N, Kahlbacher H, Schoffmann G et al. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res. 23(3), 573-579 (2006).
35. Leitner VM, Marschutz MK, Bernkop-Schnürch A. Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. Eur. J. Pharm. Sci. 18(1), 89-96 (2003).
36. Zalewska A, Zwierz K, Zolkowski K, Gindzienski A. Structure and biosynthesis of human salivary mucins. Acta Biochim. Pol. 47(4), 1067-1079 (2000).
37. Bernkop-Schnürch A, Clausen AE. Biomembrane permeability of peptides: strategies to improve their mucosal uptake. Mini Rev. Med. Chem. 2(4), 295-305 (2002).
38. Lee VHL. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Control. Release 13(2-3), 213-223 (1990).
39. Aungst BJ. Absorption enhancers: applications and advances. AAPS 14(1), 10-18 (2012).
40. Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S, Prakash S. A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis. Int. J. Nanomed. 6, 485-494 (2011).
41. Kast CE, Bernkop-Schnürch A. Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates). Stp. Pharm. Sci. 12(6), 351-356 (2002).
42. Clausen AE, Bernkop-Schnürch A. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J. Pharm. Sci. US 89(10), 1253-1261 (2000).
43. Clausen AE, Bernkop-Schnürch A. Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur. J. Pharm. Biopharm. 51(1), 25-32 (2001).
44. Bernkop-Schnürch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Release 94(1), 177-186 (2004).
45. Grafstrom R, Stead AH, Orrenius S. Metabolism of extracellular glutathione in rat small-intestinal mucosa. Eur. J. Biochem. 106(2), 571-577 (1980).
46. Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco-and bioadhesion: tethered structures and site-specific surfaces. J. Control. Release 65(1-2), 63-71 (2000).
47. Hugger ED, Audus KL, Borchardt RT. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J. Pharm. Sci. 91(9), 1980-1990 (2002).
48. Bromberg L, Alakhov V. Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers. J. Control. Release 88(1), 11-22 (2003).
49. Föger F, Schmitz T, Bernkop-Schnürch A. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27(23), 4250-4255 (2006).
50. Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. Biomaterials 27(34), 5855-5860 (2006).
51. Troutman MD, Thakker DR. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Pharm. Res. 20(8), 1192-1199 (2003).
52. Varma MV, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res. 48(4), 347-359 (2003).
53. Jha S, Karnani N, Lynn AM, Prasad R. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Biochem. Biopharm. Res. 310(3), 869-875 (2003).
54. Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J. Control. Release 111(1-2), 41-46 (2006).
55. Rahmat D, Muller C, Shahnaz G et al. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties. Drug Dev. Ind. Pharm. doi:10.310 9/03639045.2012.711834 (2012).
56. Rahmat D, Sakloetsakun D, Shahnaz G, Sarti F, Laffleur F, Schnürch AB. HEC-cysteamine conjugates: influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties. Int. J. Pharm. 422(1-2), 40-46 (2012).
57. Bal SM, Slutter B, Verheul R, Bouwstra JA, Jiskoot W. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant-and site-dependent immunogenicity in mice. Eur. J. Pharm. Sci. 45(4), 475-481 (2012).
58. Gupta H, Velpandian T, Jain S. Ion-and pH-activated novel in-situ gel system for sustained ocular drug delivery. J. Drug Target. 18(7), 499-505 (2010).
59. Shahnaz G, Iqbal J, Rahmat D et al. Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life. J. Control. Release 157(3), 375-382 (2012).
60. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev. 62(1), 59-82 (2010).
61. Malmo J, Varum KM, Strand SP. Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans. Biomacromolecules 12(3), 721-729 (2011).
62. Carlisle RC, Etrych T, Briggs SS, Preece JA, Ulbrich K, Seymour LW. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J. Gene Med. 6(3), 337-344 (2004).
63. Kommareddy S, Amiji M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem. 16(6), 1423-1432 (2005).
64. Lee D, Zhang W, Shirley SA et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm. Res. 24(1), 157-167 (2007).
65. Schmitz T, Bravo-Osuna I, Vauthier C, Ponchel G, Loretz B, Bernkop-Schnürch A. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials 28(3), 524-531 (2007).
66. Loretz B, Foger F, Werle M, Bernkop-Schnürch A. Oral gene delivery: strategies to improve stability of pDNA towards intestinal digestion. J. Drug Target. 14(5), 311-319 (2006).
67. Bernkop-Schnürch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int. J. Pharm. 194(2), 239-247 (2000).
68. Bernkop-Schnürch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control. Release 71(3), 277-285 (2001).
69. Clausen AE, Kast CE, Bernkop-Schnürch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 19(5), 602-608 (2002).
70. Barthelmes J, Dunnhaupt S, Hombach J, Bernkop-Schnürch A. Thiomer nanoparticles: stabilization via covalent cross-linking. Drug Deliv. 18(8), 613-619 (2011).
71. Bernkop-Schnürch A, Millotti G, Hoyer H, Engbersen JFJ. 6-mercaptonicotinamide-functionalized chitosan: a potential excipient for mucoadhesive drug delivery systems. J. Drug Deliv. Sci. Tech. 20(3), 181-186 (2010).
72. Kafedjiiski K, Krauland AH, Hoffer MH, Bernkop-Schnürch A. Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 26(7), 819-826 (2005).
73. Bernkop-Schnürch A, Hornof M, Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int. J. Pharm. 260(2), 229-237 (2003).
74. Hintzen F, Laffleur F, Sakloetsakun D, Leithner K, Bernkop-Schnürch A. In situ gelling properties of anionic thiomers. Drug Dev. Ind. Pharm. doi:10.3109/03639045.2011 .653813 (2012).
75. Leitner VM, Walker GF, Bernkop-Schnürch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm. 56(2), 207-214 (2003).